Intersecting Genetics of Frailty and Cardiovascular Disease

• DOI: 10.1007/s12603-021-1673-8
• Publication Date: 2021-09-15T01:02:58Z
• Authors: Y. Ahisar; G. Thanassoulis; K.N. Huang; S.M. Ohayon; Jonathan Afilalo
• Keywords: 0301 basic medicine; Sarcopenia; 0303 health sciences; 03 medical and health sciences; Frailty; Hand Strength; Cardiovascular Diseases; Humans; Genome-Wide Association Study; 3. Good health

To determine the genetic correlates of physical frailty and sarcopenia, focusing on single nucleotide polymorphisms (SNPs) in genome-wide association studies (GWAS), and to explore the genetic overlap of frailty with cardiovascular disease (CVD) and its risk factors.PubMed was systematically searched for GWAS studies investigating the association between SNPs and objective measures of physical frailty or sarcopenia. SNPs were retained if they were associated with one of the phenotypes of interest by a p-value of 5.0x10-8 or less.Ten studies were included, with a total of 237 SNPs in 181 genes being associated with physical frailty or sarcopenia; as measured by handgrip strength or lean (muscle) mass. These genes were cross-referenced in the GWAS Catalog, and many of them were found to be associated with CVD or metabolic syndrome.Evidence from GWAS has shown that frailty is associated with common genetic polymorphisms. Many of these polymorphisms have been implicated in CVD, supporting the hypothesis of a shared pathophysiology between these entities. Future studies are eagerly anticipated to map out the mechanistic links and discover therapeutic targets and novel biomarkers for frailty.